Results 231 to 240 of about 300,221 (330)
The mechanism of secondary cognitive impairment following AKI. When renal ischemic injury progresses to fibrosis, renal fibroblasts and damaged tubular cells secrete MDK, which circulates through the bloodstream, crosses the damaged BBB, and accumulates in the hippocampus tissue (an area crucial for learning and memory).
Li Lu +10 more
wiley +1 more source
Anti-VEGF neutralizing antibody delays osteomucosal healing by reducing collagen formation in mice. [PDF]
Bae EB +11 more
europepmc +1 more source
494. Engineering Immunity Against HIV — Lentiviral-Vector Mediated Delivery of Broadly Neutralizing Antibodies as Pre-Exposure Prophylaxis for HIV [PDF]
openalex +1 more source
After the intravenous injection of biomimetic and pH/ROS‐responsive PTSK@CRM, the nanoparticles can be accumulated in tumors and release Sim and KYNase to inhibit the tumor growth, regulate the metabolism of cholesterol and Kyn, and reverse the immunosuppressive tumor microenvironment.
Jiaxin Yin +6 more
wiley +1 more source
MSC‐EVs alleviate peritoneal inflammation and fibrogenesis by disrupting the H3K18la‐CCL2 axis and crosstalk between mesothelial cells and Ly6c2⁺ macrophages. Model cartoons are constructed using the Biorender website (https://www.biorender.com/), and a usage license is obtained. Abstract Peritoneal dialysis (PD), as a renal replacement therapy, relies
Qiang Huang +12 more
wiley +1 more source
A die is cast: autologous neutralizing antibody resistance shapes the HIV reservoir during uninterrupted ART. [PDF]
Archin NM.
europepmc +1 more source
A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus
Diogo M. Magnani +25 more
openalex +2 more sources
This study demonstrates that tumor‐derived IL‐35 promotes pancreatic cancer fibrosis by indirectly activating pancreatic stellate cells through IGFBP2/IGF‐1R/PI3K‐Akt and Tsp‐1/TGF‐β pathways. IL‐35 blockade reduces stromal fibrosis, restores chemosensitivity, and synergizes with gemcitabine‐based regimens, highlighting IL‐35 as a promising therapeutic
Hui Li +14 more
wiley +1 more source

